F105 Advancing Care and Advocacy in Dermatology
DESCRIPTION
This forum aims to highlight the importance of building healthy communities. It will also highlight considerations of the healthcare needs of underserved patient populations. This session is intended for a broad audience, where we hope to engage in valuable discussion and consider a variety of perspectives and experiences as they pertain to these topics. The session will feature current leaders in this work and will present opportunities for participants to learn more about and support this work as it relates to personal relationships, mentorship, sponsorship, research, and education.
LEARNING OBJECTIVES
Discuss strategies to building healthier communities
Discuss steps to improve care of underserved patient populations
SCHEDULE
3:30 PM
Climate Advocacy and Vulnerable Populations
Eva R. Parker, MD, FAAD
3:50 PM
Potential Impact of Medicaid Cuts on Care for Underserved Communities
Klint Peebles, MD, FAAD
4:10 PM
Enhancing Healthcare Delivery for Rural Populations
Robert T. Brodell, MD, FAAD
4:30 PM
Practical Ways to Address Social Drivers of Health in Dermatology
Aileen Chang, MD, FAAD
4:50 PM
Advancing Care for Individuals Living with Disabilities
Haley Naik, MD, FAAD
5:10 PM
Getting Involved in Health Policy and Advocacy
Elizabeth A. Kiracofe, MD, FAAD
DIRECTOR
E. Nikki Pritchett, MD, MPH, FAAD
CO-DIRECTORS
Janiene Luke, MD, FAAD
Rebecca Vasquez, MD, FAAD
SPEAKERS
Robert T. Brodell, MD, FAAD
University of Mississippi Medical Center
Aileen Chang, MD, FAAD
University of California, San Francisco
Elizabeth A. Kiracofe, MD, FAAD
Haley Naik, MD, FAAD
Eva R. Parker, MD, FAAD
Vanderbilt University Medical Center
Klint Peebles, MD, FAAD
DISCLOSURES
Robert T. Brodell, MD, FAAD
Amgen – Consultant (1099 relationship)(Honoraria); Corrona, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Regeneron – Consultant (1099 relationship)(Honoraria); Sanofi – Investigator(Grants/Research Funding); VeraDermics Inc. – Stockholder(Stock);
Aileen Chang, MD, FAAD
Abridge AI Inc. – Employee (w-2 relationship)(Stock);
Elizabeth A. Kiracofe, MD, FAAD
Arcutis Biotherapeutics – Speaker(Fees); CeraVe – Consultant (1099 relationship)(Honoraria); Dermavant Sciences, Inc. – Advisory Board(Fees); Eli Lilly – Speaker(Fees); Galderma – Speaker(Fees); Incyte Corporation – Speaker(Fees); Sanofi/Regeneron – Speaker(Fees); UCB – Speaker(Fees);
Janiene Luke, MD, FAAD
Arcutis Biotherapeutics – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria);
Haley Naik, MD, FAAD
23andMe – Consultant(Honoraria); AbbVie – Consultant(Honoraria), Other(Grants/Research Funding); Aristea Therapeutics, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Dava Oncology – Consultant(Honoraria); Johnson and Johnson – Consultant(Honoraria); Medscape – Consultant (1099 relationship)(Fees); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Radera Biotherapeutics, Inc. – Stockholder Private Company(Stock Options); Radera, Inc. – Stockholder Private Company(Stock Options); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant (1099 relationship)(Fees);
Eva R. Parker, MD, FAAD
L'Oreal – Advisory Board(Honoraria), Speaker(Honoraria);
Klint Peebles, MD, FAAD
Kaiser Permanente – Employee(Salary);
E. Nikki Pritchett, MD, MPH, FAAD
Kimberly Clark – Consultant (1099 relationship)(Fees); Projects in Knowledge Powered by Kaplan – Consultant (1099 relationship)(Fees);
Rebecca Vasquez, MD, FAAD
Incyte – Consultant (1099 relationship)(Honoraria);